Defeating Antibiotic- and Phage-Resistant Enterococcus faecalis Using a Phage Cocktail in Vitro and in a Clot Model

The deteriorating effectiveness of antibiotics is propelling researchers worldwide towards alternative techniques such as phage therapy: curing infectious diseases using viruses of bacteria called bacteriophages. In a previous paper, we isolated phage EFDG1, highly effective against both planktonic...

Full description

Bibliographic Details
Main Authors: Leron Khalifa, Daniel Gelman, Mor Shlezinger, Axel Lionel Dessal, Shunit Coppenhagen-Glazer, Nurit Beyth, Ronen Hazan
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-02-01
Series:Frontiers in Microbiology
Subjects:
Online Access:http://journal.frontiersin.org/article/10.3389/fmicb.2018.00326/full
_version_ 1818173956938530816
author Leron Khalifa
Daniel Gelman
Mor Shlezinger
Mor Shlezinger
Axel Lionel Dessal
Shunit Coppenhagen-Glazer
Nurit Beyth
Nurit Beyth
Ronen Hazan
author_facet Leron Khalifa
Daniel Gelman
Mor Shlezinger
Mor Shlezinger
Axel Lionel Dessal
Shunit Coppenhagen-Glazer
Nurit Beyth
Nurit Beyth
Ronen Hazan
author_sort Leron Khalifa
collection DOAJ
description The deteriorating effectiveness of antibiotics is propelling researchers worldwide towards alternative techniques such as phage therapy: curing infectious diseases using viruses of bacteria called bacteriophages. In a previous paper, we isolated phage EFDG1, highly effective against both planktonic and biofilm cultures of one of the most challenging pathogenic species, the vancomycin-resistant Enterococcus (VRE). Thus, it is a promising phage to be used in phage therapy. Further experimentation revealed the emergence of a mutant resistant to EFDG1 phage: EFDG1r. This kind of spontaneous resistance to antibiotics would be disastrous occurrence, however for phage-therapy it is only a minor hindrance. We quickly and successfully isolated a new phage, EFLK1, which proved effective against both the resistant mutant EFDG1r and its parental VRE, Enterococcus faecalis V583. Furthermore, combining both phages in a cocktail produced an additive effect against E. faecalis V583 strains regardless of their antibiotic or phage-resistance profile. An analysis of the differences in genome sequence, genes, mutations, and tRNA content of both phages is presented. This work is a proof-of-concept of one of the most significant advantages of phage therapy, namely the ability to easily overcome emerging resistant bacteria.
first_indexed 2024-12-11T19:36:45Z
format Article
id doaj.art-dea01fd0bb504539975f3c7fb39dba35
institution Directory Open Access Journal
issn 1664-302X
language English
last_indexed 2024-12-11T19:36:45Z
publishDate 2018-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Microbiology
spelling doaj.art-dea01fd0bb504539975f3c7fb39dba352022-12-22T00:53:09ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2018-02-01910.3389/fmicb.2018.00326286413Defeating Antibiotic- and Phage-Resistant Enterococcus faecalis Using a Phage Cocktail in Vitro and in a Clot ModelLeron Khalifa0Daniel Gelman1Mor Shlezinger2Mor Shlezinger3Axel Lionel Dessal4Shunit Coppenhagen-Glazer5Nurit Beyth6Nurit Beyth7Ronen Hazan8Faculty of Dental Sciences, Hadassah School of Dental Medicine, Hebrew University of Jerusalem, Jerusalem, IsraelFaculty of Dental Sciences, Hadassah School of Dental Medicine, Hebrew University of Jerusalem, Jerusalem, IsraelFaculty of Dental Sciences, Hadassah School of Dental Medicine, Hebrew University of Jerusalem, Jerusalem, IsraelDepartment of Prosthodontics, Hadassah School of Dental Medicine, Hebrew University of Jerusalem, Jerusalem, IsraelFaculty of Dental Sciences, Hadassah School of Dental Medicine, Hebrew University of Jerusalem, Jerusalem, IsraelFaculty of Dental Sciences, Hadassah School of Dental Medicine, Hebrew University of Jerusalem, Jerusalem, IsraelFaculty of Dental Sciences, Hadassah School of Dental Medicine, Hebrew University of Jerusalem, Jerusalem, IsraelDepartment of Prosthodontics, Hadassah School of Dental Medicine, Hebrew University of Jerusalem, Jerusalem, IsraelFaculty of Dental Sciences, Hadassah School of Dental Medicine, Hebrew University of Jerusalem, Jerusalem, IsraelThe deteriorating effectiveness of antibiotics is propelling researchers worldwide towards alternative techniques such as phage therapy: curing infectious diseases using viruses of bacteria called bacteriophages. In a previous paper, we isolated phage EFDG1, highly effective against both planktonic and biofilm cultures of one of the most challenging pathogenic species, the vancomycin-resistant Enterococcus (VRE). Thus, it is a promising phage to be used in phage therapy. Further experimentation revealed the emergence of a mutant resistant to EFDG1 phage: EFDG1r. This kind of spontaneous resistance to antibiotics would be disastrous occurrence, however for phage-therapy it is only a minor hindrance. We quickly and successfully isolated a new phage, EFLK1, which proved effective against both the resistant mutant EFDG1r and its parental VRE, Enterococcus faecalis V583. Furthermore, combining both phages in a cocktail produced an additive effect against E. faecalis V583 strains regardless of their antibiotic or phage-resistance profile. An analysis of the differences in genome sequence, genes, mutations, and tRNA content of both phages is presented. This work is a proof-of-concept of one of the most significant advantages of phage therapy, namely the ability to easily overcome emerging resistant bacteria.http://journal.frontiersin.org/article/10.3389/fmicb.2018.00326/fullbacteriophagesEnterococcus faecalisantibiotic-resistancephage therapyphage-resistancephage cocktail
spellingShingle Leron Khalifa
Daniel Gelman
Mor Shlezinger
Mor Shlezinger
Axel Lionel Dessal
Shunit Coppenhagen-Glazer
Nurit Beyth
Nurit Beyth
Ronen Hazan
Defeating Antibiotic- and Phage-Resistant Enterococcus faecalis Using a Phage Cocktail in Vitro and in a Clot Model
Frontiers in Microbiology
bacteriophages
Enterococcus faecalis
antibiotic-resistance
phage therapy
phage-resistance
phage cocktail
title Defeating Antibiotic- and Phage-Resistant Enterococcus faecalis Using a Phage Cocktail in Vitro and in a Clot Model
title_full Defeating Antibiotic- and Phage-Resistant Enterococcus faecalis Using a Phage Cocktail in Vitro and in a Clot Model
title_fullStr Defeating Antibiotic- and Phage-Resistant Enterococcus faecalis Using a Phage Cocktail in Vitro and in a Clot Model
title_full_unstemmed Defeating Antibiotic- and Phage-Resistant Enterococcus faecalis Using a Phage Cocktail in Vitro and in a Clot Model
title_short Defeating Antibiotic- and Phage-Resistant Enterococcus faecalis Using a Phage Cocktail in Vitro and in a Clot Model
title_sort defeating antibiotic and phage resistant enterococcus faecalis using a phage cocktail in vitro and in a clot model
topic bacteriophages
Enterococcus faecalis
antibiotic-resistance
phage therapy
phage-resistance
phage cocktail
url http://journal.frontiersin.org/article/10.3389/fmicb.2018.00326/full
work_keys_str_mv AT leronkhalifa defeatingantibioticandphageresistantenterococcusfaecalisusingaphagecocktailinvitroandinaclotmodel
AT danielgelman defeatingantibioticandphageresistantenterococcusfaecalisusingaphagecocktailinvitroandinaclotmodel
AT morshlezinger defeatingantibioticandphageresistantenterococcusfaecalisusingaphagecocktailinvitroandinaclotmodel
AT morshlezinger defeatingantibioticandphageresistantenterococcusfaecalisusingaphagecocktailinvitroandinaclotmodel
AT axellioneldessal defeatingantibioticandphageresistantenterococcusfaecalisusingaphagecocktailinvitroandinaclotmodel
AT shunitcoppenhagenglazer defeatingantibioticandphageresistantenterococcusfaecalisusingaphagecocktailinvitroandinaclotmodel
AT nuritbeyth defeatingantibioticandphageresistantenterococcusfaecalisusingaphagecocktailinvitroandinaclotmodel
AT nuritbeyth defeatingantibioticandphageresistantenterococcusfaecalisusingaphagecocktailinvitroandinaclotmodel
AT ronenhazan defeatingantibioticandphageresistantenterococcusfaecalisusingaphagecocktailinvitroandinaclotmodel